Volume 16, Number 6 (Nov/Dec 2025)

Within this issue, read about a quality improvement project that improved the appropriate prescribing rate of olanzapine for chemotherapy-induced nausea and vomiting. Advanced practice providers (APPs) play a key role in detecting and managing adverse events in clinical practice, and this issue’s integrative review examines their role in early-phase oncology clinical trials. Learn about optimizing the dosing of regorafenib in patients with metastatic colorectal cancer, and gain insights on the long-term safety of lorlatinib for ALK-positive metastatic non-small cell lung cancer through an illustrative case study.

The development of a blood factor product formulary helped maximize patient outcomes and minimize adverse events at a large health system, as described in a Practice Matters article. In another cancer center, a formal career pathway program provided a structured pathway for the promotion and continuous career development of APPs.

Finally, read the first-hand accounts of clinical pharmacists as they describe their role in patient education and medication management, and explore ways for radiation oncology APPs to get involved in research.